Pentylone

Pentylone
Clinical data
Other names	β-Keto-Methylbenzodioxolylpentanamine, βk-Methyl-K, βk-MBDP, methylenedioxypentedrone, 1‐(3,4‐methylenedioxyphenyl)‐2‐(methylamino)pentan‐1‐one
ATC code	none;
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); DE: Anlage I (Authorized scientific use only); UK: Class B; US: Schedule I; Illegal in Sweden and Finland;
Identifiers
	IUPAC name (±)-1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one;
CAS Number	698963-77-8 ; 17763-01-8 (hydrochloride);
PubChem CID	60208608;
ChemSpider	29786041 ;
UNII	IGN39WGH0Q;
CompTox Dashboard (EPA)	DTXSID401014183 ;
Chemical and physical data
Formula	C13H17NO3
Molar mass	235.283 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c2cc1OCOc1cc2C(=O)C(NC)CCC;
	InChI InChI=1S/C13H17NO3/c1-3-4-10(14-2)13(15)9-5-6-11-12(7-9)17-8-16-11/h5-7,10,14H,3-4,8H2,1-2H3 ; Key:DFMLULIEUUXXSA-UHFFFAOYSA-N ;
	(what is this?) (verify)

Pentylone is a stimulant developed in the 1960s. It is a substituted cathinone that has been identified in some samples of powders sold as "NRG-1", along with varying blends of other cathinone derivatives including flephedrone, MDPBP, MDPV, and 4-MePPP. It was also found in combination with 4-MePPP being sold as "NRG-3". Reports indicate side effects include paranoia, agitation, and insomnia, with effects lasting for several days at high doses.